7.5 mg tirzepatide compound TrimRX 2ML Tirzepatide + Glycine +

135 South Bryn Mawr Ave, Suite 220, Bryn Mawr, PA 19010

Meanwhile, a post-hoc analysis of the STEP 1 and STEP 4 trials showed that semaglutide 2.4 mg was associated with an approximately 60% reduction of the 10-years risk of T2D according to the Cardiometabolic Disease Staging (CMDS) calculator, regardless of patients baseline glycemic status 74

It is not entirely clear to what extent endogenous GLP-1 activates all the reported GLP-1 receptor expressing neurons and to what extent it depends on the CART peptide especially in type 2 diabetes or obesity

This design maintains sterility and prevents contamination of the lyophilized (freeze-dried) powder or reconstituted solution inside

This is not a flaw in the compounding model